At the General Shareholders’ Meeting of Biosearch Life, the company presented the results for the first half of 2020. Biosearch’s turnover stood at 14.3 million euros in the first half of 2020, representing growth of 25 , 8% compared to the same period of the previous year, driven by the organic growth of its three business units: botanical extracts, probiotics and lipids, according to the advance of results published by the company.
The plant extracts business was the main driver of total growth, increased by 44.2% to 5.5 million euros, mainly due to the increasing demand for Caronositol and the strong interest in products that strengthen the immune system worldwide.
On its side, the probiotics business registered a growth of 47.4%, standing at 3.2 million euros, driven mainly by the Women’s Health segment.
The lipid business continued its positive trend, with an increase in sales of 5.4%, reaching 5.4 million euros.
Service revenues decreased in the period, in line with the company’s strategy of reducing this line of activity.
Biosearch LIfe will present the final results of the first semester on Monday, July 27.